Tomorrow Health Moves to Fully Automate DME Orders
The healthcare technology company has launched its Clinical Rules Engine, which should streamline and systematize DME orders, and ultimately drive more care to the home setting.
- By David Kopf
- Dec 08, 2022
With the release of its new Clinical Rules Engine, healthcare technology company Tomorrow Health reports it has automated the order lifecycle for all DME codes.
Tomorrow Health aims to provide a platform that makes it easier for payers, health plans, patients and providers to smooth the transition to home-based care and the ordering of services for homecare patients, such as DME.
The release of the Clinical Rules Engine and its automation of DME orders should ultimately help payers drive more care to the home, according to Tomorrow Health, which noted the engine is the first step in its long-term plan to automate home healthcare services spanning tens of thousands of HCPCS codes.
Using the new HCPCS code automation features, clinicians are guided through a one- to five-question, dynamically rendered digital form that is customized to a patient's participating health insurance plan. Upon form completion, the order is routed to the home-based care supplier best suited for the patient's needs.
Tomorrow Health said that process trims a one- to two-week process to five days or less for most orders, with half delivered in two days. It added that the new feature is currently in active rollout with referring care providers.
"Fully automating one of the most cumbersome and technical parts of the home healthcare coding process is a big step forward for drifting down readmissions and restoring lower-cost home settings as patients' primary place of care," said Vijay Kedar, co-founder and CEO of Tomorrow Health
"Tomorrow Health makes documentation and order fulfillment much easier, which helps us submit claims and receive payment more timely," said Shawna Morton, vice president of Contracts at Rotech Healthcare.
David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on LinkedIn at linkedin.com/in/dkopf/ and on Twitter at @postacutenews.